These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7066204)

  • 21. Aortic thrombosis in a neonate with hereditary antithrombin III deficiency: successful outcome with thrombolytic and replacement treatment.
    Sánchez J; Velasco F; Alvarez R; Román J; Torres A
    Acta Paediatr; 1996 Feb; 85(2):245-7. PubMed ID: 8640060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of hemostatic balance with antithrombin III replacement therapy in a case of liver cirrhosis associated with recurrent venous thrombosis.
    Carmassi F; Morale M; De Negri F; Carrai M
    J Mol Med (Berl); 1995 Feb; 73(2):89-93. PubMed ID: 7627635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Properties and catabolism of heat treated antithrombin III concentrate.
    Tengborn L; Frohm B; Nilsson LE; Johansson L; Andersson LO
    Thromb Res; 1987 Dec; 48(6):701-11. PubMed ID: 3433260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical experience with antithrombin III concentrate in treatment of congenital and acquired deficiency of antithrombin. The Antithrombin III Study Group.
    Schwartz RS; Bauer KA; Rosenberg RD; Kavanaugh EJ; Davies DC; Bogdanoff DA
    Am J Med; 1989 Sep; 87(3B):53S-60S. PubMed ID: 2679072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of pregnancy in women with antithrombin III congenital defect: report of four cases.
    De Stefano V; Leone G; De Carolis S; Ferrelli R; Di Donfrancesco A; Moneta E; Bizzi B
    Thromb Haemost; 1988 Apr; 59(2):193-6. PubMed ID: 3164529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparin-antithrombin III binding. In vitro and in vivo studies.
    Chan V; Chan TK
    Haemostasis; 1979; 8(6):373-89. PubMed ID: 511016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neonatal antithrombin III.
    Peters M; Jansen E; ten Cate JW; Kahlé LH; Ockelford P; Breederveld C
    Br J Haematol; 1984 Dec; 58(4):579-87. PubMed ID: 6518134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hereditary antithrombin III deficiency: case report and review of recent therapeutic advances.
    Miller N; Hultin MB; Gounder M; Zarrabi MH
    Am J Hematol; 1986 Feb; 21(2):215-21. PubMed ID: 3942133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homozygous variant of antithrombin with lack of affinity for heparin: management of severe thrombotic complications associated with intrauterine fetal demise.
    Bauters A; Zawadzki C; Bura A; Théry C; Watel A; Subtil D; Aiach M; Emmerich J; Jude B
    Blood Coagul Fibrinolysis; 1996 Oct; 7(7):705-10. PubMed ID: 8958394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The plasma turnover of transfused antithrombin concentrate in patients with acquired antithrombin deficiency.
    Harper PL; Park GR; Carrell RW
    Transfus Med; 1996 Mar; 6(1):45-50. PubMed ID: 8696447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inherited antithrombin III deficiency and cerebral thrombosis in a child.
    Ambruso DR; Jacobson LJ; Hathaway WE
    Pediatrics; 1980 Jan; 65(1):125-31. PubMed ID: 7355006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antithrombin III concentrate: its catabolism in health and in antithrombin III deficiency.
    Tengborn L; Frohm B; Nilsson LE; Nilsson IM
    Scand J Clin Lab Invest; 1981 Sep; 41(5):469-77. PubMed ID: 7031840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Perioperative management for transurethral resection of bladder tumor (TUR-Bt) associated with congenital antithrombin III deficiency].
    Mizuno J; Kato S; Namai S; Komiya Y; Kuwana Y; Morita S
    Masui; 2009 Dec; 58(12):1524-7. PubMed ID: 20055199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antithrombin III deficiency: decreased synthesis of a biochemically normal molecule.
    Ambruso DR; Leonard BD; Bies RD; Jacobson L; Hathaway WE; Reeve EB
    Blood; 1982 Jul; 60(1):78-83. PubMed ID: 7082848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of antithrombin III concentrates].
    Vinazzer H
    Beitr Infusionsther; 1989; 24():151-8. PubMed ID: 2481532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hereditary antithrombin III deficiency and pregnancy: report of two cases and review of the literature.
    Nelson DM; Stempel LE; Brandt JT
    Obstet Gynecol; 1985 Jun; 65(6):848-53. PubMed ID: 4039808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Management with antithrombin III concentrate in a pregnant woman with hereditary antithrombin III deficiency].
    Higuchi M; Konya H; Tanaka H; Masuda H; Nishida Y; Koyama T; Suehiro A; Kakishita E; Ishita K
    Rinsho Ketsueki; 1990 Sep; 31(9):1544-7. PubMed ID: 2246830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human antithrombin III heterogeneity.
    Williams L; Murano G
    Blood; 1981 Feb; 57(2):229-32. PubMed ID: 6160891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antithrombin III transfusion in patients with hepatic cirrhosis.
    Schipper HG; ten Cate JW
    Br J Haematol; 1982 Sep; 52(1):25-33. PubMed ID: 7115627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antithrombin III concentrates.
    Menache D
    Hematol Oncol Clin North Am; 1992 Oct; 6(5):1115-20. PubMed ID: 1400075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.